Press "Enter" to skip to content

New patent expiration for Osi Pharms drug TARCEVA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Osi Pharms drug TARCEVA

Annual Drug Patent Expirations for TARCEVA
Annual Drug Patent Expirations for TARCEVA

Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for TARCEVA.

The generic ingredient in TARCEVA is erlotinib hydrochloride. One supplier is listed for this compound. Additional details are available on the erlotinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Osi Pharms drug TARCEVA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions